Physician profile
Amit Kumar Garg
NPI 1932181559
$5,197.41
in general payments reported to CMS, 2019-2025
31 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $339 · 2021: $911 · 2022: $975 · 2023: $1,040 · 2024: $980 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,445.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $645.93 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $557.48 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $469.27 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $428.78 | 2020-2023 | Brilinta, Farxiga |
| Merck Sharp & Dohme LLC | $373.05 | 2019-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $370.44 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.94 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $286.18 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $275.15 | 2021-2025 | Nexletol |
| Pfizer INC. | $272.65 | 2019-2025 | |
| Boston Scientific Corporation | $239.90 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Amarin Pharma, INC. | $187.88 | 2019-2022 | |
| Cook Medical LLC | $123.90 | 2023 | Zilver Ptx |
| Regeneron Healthcare Solutions, INC. | $102.71 | 2019-2021 | |
| Scpharmaceuticals INC. | $60.01 | 2023-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $56.49 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $49.36 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $45.00 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $37.75 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.71 | 2024-2025 | |
| Medtronic, INC. | $36.48 | 2024 | Linq II, Reveal Linq |
| Philips North America LLC | $35.83 | 2020-2025 | Diagnostic Ecg Service |
| Biotronik INC. | $30.82 | 2019-2020 | |
| Medicomp INC | $28.48 | 2021-2024 | Telepatch Cardiac Monitor |
| Abbott Laboratories | $23.94 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Actelion Pharmaceuticals US, INC. | $23.10 | 2024 | Opsumit, Uptravi |
| Vital Connect, INC | $19.00 | 2025 | Vitalpatch Rtm |
| Edwards Lifesciences Corporation | $17.25 | 2020 | |
| Heartflow, INC. | $14.31 | 2023 | Ffrct |
| Baxter Healthcare | $13.91 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lundbeck LLC | $12.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.